HealthiosXchange, also known as H/X, announced on Friday that the first lead syndicator in its Champion Program, California-based Leonhardt Ventures, will introduce the world’s first and only heart failure pacemaker called Myostim Pacer. It is designed to recruit reparative stem cells to damaged and weakened heart tissue.
In its role as a lead syndicate investor in the program, Leonhardt Venture is inviting its network of other accredited angel investors to register with H/X and become syndicate investors. They will agree to pay “carry” for the lead syndicate investor’s access, governance and expertise in managing the syndicate designed for investment in multiple companies. The company managed the syndicate and provides ongoing oversight of the investment. Lead’s “carry” is collected upon a successful exit.
H/X does not have a “carry.” Instead, as a FINRA-regulated broker/dealer, the company charges a one-time success fee on the capital raised by a syndicate, thereby allowing all the profits to be distributed to the investors.
CEO of H/X Scott Jordan stated, “Our Champions Program is making it more efficient for investors such as Leonhardt Venture to raise money for great companies like MyoStim. There are several important benefits of syndicating deals for both the lead investors and the syndicate investors. For the syndicate investors, they get the benefit of the lead investor’s deal flow, governance, and savvy in picking and managing investments, and they have the opportunity to invest less than the startup’s minimum.”
He continued, “For lead investors like Leonhardt Ventures, they gain access to larger amounts of capital to invest in great emerging companies such as MyoStim, as well as access to more deals in those companies with higher minimum commitments.”
H/X is an equity crowdfunding portal and broker/dealer that raised funds under Rule 506 (b). As a member-only site, H/X offers private placements to accredited investors. 2000 accredit investors, along with emerging growing companies, investment professionals, and strategic buyers are registered members of H/X